Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. is a gene therapy company based in Durham, NC. It is a wholly owned subsidiary of Bayer AG and is dedicated to developing life-saving medicines and advancing genetic technology. The company focuses on a range of genetic diseases and has a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington's disease, limb-girdle muscular dystrophy, and multiple system disorders.
With a mission to transform medicine and change lives, Asklepios BioPharmaceutical is at the forefront of AAV gene therapy research. Founded by Dr. Jude Samulski in 1984, the company aims to utilize viruses to combat genetic diseases. Their innovative approach and commitment to advancing gene therapy make them a leading player in the field of genetic medicine.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.